Developer docs
API playgroundTry for free, no card

Search company profiles

Clinical Pharmacogenetics Implementation Consortium (CPIC)

Full company profile

uuid0004w34

Namestring
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Legal namestring
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Websiteurl
cpicpgx.org
Company typeenum
Private
Founded yearint
2009
Descriptiontext

CPIC is an international nonprofit research consortium founded in 2009 as a joint initiative between PharmGKB and the Pharmacogenomics Research Network (PGRN). It is managed jointly at Stanford University and St. Jude Children's Research Hospital and is funded by NIH grants (U24HG013077) from NHGRI, NICHD, NIDA, and NCI. CPIC's mission is to address barriers to clinical implementation of pharmacogenetic testing by creating, curating, and publishing freely available, peer-reviewed, evidence-based gene/drug clinical practice guidelines. Its core output is a library of 56+ peer-reviewed guideline publications covering dozens of gene-drug pairs (e.g., CYP2D6, CYP2C19, CYP2C9, TPMT, NUDT15, SLCO1B1) across oncology, psychiatry, cardiology, and other therapeutic areas, indexed in PubMed and published in Clinical Pharmacology and Therapeutics.

CPIC's technical stack comprises (i) human-readable guideline documents with systematic evidence grading, (ii) a structured CPIC Database and REST API (api.clinpgx.org) exposing gene-drug pairs, allele function assignments, and diplotype-to-phenotype mappings, (iii) GitHub-hosted versioned data releases (cpicpgx/cpic-data), and (iv) Informatics Working Group resources for EHR/Clinical Decision Support integration. Companion assets within the broader ClinPGx ecosystem include PharmGKB (curated knowledge base) and PharmCAT (variant calling and phenotype reporting). Endorsements from AMP, ASCPT, ASHP, CAP, and ClinGen lend institutional legitimacy, and CPIC® is a registered service mark of the U.S. Department of Health & Human Services.

CPIC does not earn commercial revenue. All guidelines and data are released under Creative Commons (CC0 for guidelines, CC BY-SA for data) at no cost to users worldwide. Operating funding flows from NIH grants, supplemented by an international consortium membership program that requires a signed MOU. End users include healthcare providers, clinical laboratories, researchers, EHR vendors, and indirectly patients receiving PGx-guided therapy; documented clinical outcomes include a reported 30% reduction in adverse drug reactions in pretherapeutic PGx panel testing studies.

Short descriptiontext

CPIC is a nonprofit international consortium that develops and freely distributes peer-reviewed, evidence-based pharmacogenetic clinical practice guidelines and a structured gene-drug database, serving clinicians, clinical laboratories, researchers, and EHR vendors worldwide under NIH funding.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMemphis, United States
HQ citystring
Memphis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacogenomics guidelines, clinical decision support, gene-drug pair annotations, EHR integration, pharmacogenetic testing
Industry1 code
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Pharmacogenomics Guidelines
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1NIH Funding
TypeLicensing Royalties
Description

CPIC is managed at Stanford University and St. Jude Children's Research Hospital under NIH grants (U24HG013077). As a non-profit research consortium, CPIC operations are funded through NIH/NHGRI/NICHD/NIDA/NCI grants rather than commercial revenue generation.

clinpgx.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Others
Pricing details1 tier
1Free access to all CPIC resources
ModelFreemiumBilling cadenceOthers
Notes

All CPIC resources are freely available under Creative Commons CC0 1.0 Public Domain Dedication. No fees or licensing costs required.

clinpgx.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CPIC is an international consortium that creates, curates, and posts freely available, peer-reviewed, evidence-based gene/drug clinical practice guidelines that translate pharmacogenetic test results into actionable prescribing decisions. Core offerings include the CPIC Guidelines, a structured CPIC Database with a public REST API (api.clinpgx.org), gene reference tables, allele function/diplotype-phenotype resources, and informatics tools for Electronic Health Records and Clinical Decision Support integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • PGx-guided therapy can reduce adverse drug reactions and healthcare costs
+1 more record
Product overview1 text field

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international consortium that develops and freely distributes peer-reviewed, evidence-based clinical practice guidelines for pharmacogenetics. CPIC's core offering is its guidelines (covering gene-drug pairs), accessible via a public API and database. The ecosystem includes PharmGKB (knowledge base), CPIC (guidelines), and PharmCAT (variant identification tool). CPIC guidelines translate genetic laboratory results into actionable prescribing decisions and are indexed in PubMed. The consortium provides supplementary resources including gene tables, allele downloads, SOPs for allele curation, implementation guides for EHR integration, and educational materials. All CPIC resources are freely available under Creative Commons (CC0 for guidelines, CC BY-SA for data).

Product and service6 records
1CPIC Guidelines
CategoryClinical Practice Guidelines
Description

Peer-reviewed, evidence-based, updatable clinical practice guidelines that translate pharmacogenetic test results into actionable prescribing decisions for specific gene-drug pairs. Guidelines follow standardized formats with systematic grading of evidence and clinical recommendations, published in partnership with Clinical Pharmacology and Therapeutics and indexed in PubMed.

2CPIC Database and API
CategoryStructured Data and API
Description

Structured access to CPIC guideline data including gene-drug pair information, allele function assignments, diplotype-to-phenotype translations, and clinical recommendations. Available via REST API and database downloads with versioned releases on GitHub.

3Gene Tables
CategoryReference Data Resource
Description

Reference tables providing curated PGx evidence for genes, including allele function and diplotype-phenotype relationships for pharmacogenes used by clinicians and laboratories.

4CPIC Publications
CategoryKnowledge Resource / Publications
Description

Repository of 56+ peer-reviewed scientific articles written or contributed to by the ClinPGx team, covering implementation guidelines, literature annotations, and supporting research, available as downloadable TSV.

5CPIC Informatics Working Group Resources
CategoryInformatics / Implementation Resource
Description

Technical resources supporting EHR integration, including comprehensive genotype-to-phenotype translation tables, clinical decision support recommendations, and formal knowledge representations for electronic health records.

6PharmCAT
CategoryCompanion Software Tool
Description

A companion tool for identifying pharmacogenetic variants from genomic data and generating phenotype reports, developed as part of the ClinPGx ecosystem alongside PharmGKB and CPIC. Managed at Stanford University and University of Pennsylvania.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

PharmGKB and CPIC have a foundational partnership. CPIC started as a shared project between PharmGKB and the Pharmacogenomics Research Network (PGRN) in 2009. PharmGKB provides the infrastructure for ClinPGx, which comprises PharmGKB, CPIC, and PharmCAT. CPIC guidelines are hosted on the ClinPGx platform.

2Pharmacogenomics Research Network (PGRN)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CPIC started as a shared project between PharmGKB and PGRN in 2009. PGRN is a research network focused on pharmacogenomics research that collaborated with PharmGKB to launch CPIC.

clinpgx.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

AMP has endorsed CPIC's Term Standardization for Clinical Pharmacogenetics Test Results Project. This endorsement supports the standardization of pharmacogenetic test result terminology across clinical laboratories.

4American Society for Clinical Pharmacology and Therapeutics (ASCPT)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

ASCPT Board of Directors has endorsed CPIC guidelines. CPIC guidelines are published in partnership with ASCPT's journal Clinical Pharmacology and Therapeutics.

clinpgx.org
5American Society of Health-System Pharmacists (ASHP)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

ASHP has endorsed multiple CPIC guidelines, indicating support for the use of pharmacogenetic guidelines in health-system pharmacy practice.

clinpgx.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

CAP has stated that it 'applauds and supports the objectives, processes and work completed' by CPIC, recognizing efforts to help clinicians, laboratories, healthcare providers, and vendors implement pharmacogenetics.

7ClinGen (Clinical Genome Resource)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ClinGen references CPIC guidelines. ClinPGx is an affiliate grant of ClinGen and works with ClinGen and ClinVar to improve integration of pharmacogenomics within broader genomic medicine. CPIC's Steering Committee is referred to as CPIC's External Expert Panel.

clinpgx.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers7 records
1PharmCAT
TypeDirect peer
Description

Companion tool in the ClinPGx ecosystem that calls PGx variants from genomic data and produces phenotype reports that feed directly into CPIC guidelines for clinical interpretation.

TypeDirect peer
Description

Foundational partner and sister organization in the ClinPGx ecosystem; together with CPIC provides annotation, evidence, and implementation assets for pharmacogenomics, and shares NIH funding and Stanford stewardship.

TypeDirect peer
Description

NIH-funded consortium that defines clinical relevance of genes and variants; CPIC is an affiliate grant of ClinGen, and ClinGen references CPIC guidelines to integrate PGx into broader genomic medicine.

TypeDirect peer
Description

Produces widely adopted, evidence-based clinical practice guidelines (for oncology); analogous operating model to CPIC in authoring and disseminating consensus-driven, peer-reviewed clinical guidance.

TypeDirect peer
Description

Professional society that issues evidence-based clinical genomics guidelines and standards overlapping CPIC's domain; relevant comparator for clinical genomics guideline development and dissemination.

TypeDirect peer
Description

Endorser of CPIC's Term Standardization project and a peer organization producing molecular pathology practice guidelines; comparable in producing clinical and laboratory standards for genomic testing.

7Pharmacogenomics Research Network (PGRN)
TypeDirect peer
Description

Co-founding organization of CPIC in 2009; NIH-funded research network advancing pharmacogenomics research with overlapping scientific leadership and mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinical Pharmacogenetics Implementation Consortium (CPIC)

Clinical Pharmacogenomics Guidelinescpicpgx.org

CPIC is a nonprofit international consortium that develops and freely distributes peer-reviewed, evidence-based pharmacogenetic clinical practice guidelines and a structured gene-drug database, serving clinicians, clinical laboratories, researchers, and EHR vendors worldwide under NIH funding.

What Clinical Pharmacogenetics Implementation Consortium (CPIC) does

CPIC is an international nonprofit research consortium founded in 2009 as a joint initiative between PharmGKB and the Pharmacogenomics Research Network (PGRN). It is managed jointly at Stanford University and St. Jude Children's Research Hospital and is funded by NIH grants (U24HG013077) from NHGRI, NICHD, NIDA, and NCI. CPIC's mission is to address barriers to clinical implementation of pharmacogenetic testing by creating, curating, and publishing freely available, peer-reviewed, evidence-based gene/drug clinical practice guidelines. Its core output is a library of 56+ peer-reviewed guideline publications covering dozens of gene-drug pairs (e.g., CYP2D6, CYP2C19, CYP2C9, TPMT, NUDT15, SLCO1B1) across oncology, psychiatry, cardiology, and other therapeutic areas, indexed in PubMed and published in Clinical Pharmacology and Therapeutics.

CPIC's technical stack comprises (i) human-readable guideline documents with systematic evidence grading, (ii) a structured CPIC Database and REST API (api.clinpgx.org) exposing gene-drug pairs, allele function assignments, and diplotype-to-phenotype mappings, (iii) GitHub-hosted versioned data releases (cpicpgx/cpic-data), and (iv) Informatics Working Group resources for EHR/Clinical Decision Support integration. Companion assets within the broader ClinPGx ecosystem include PharmGKB (curated knowledge base) and PharmCAT (variant calling and phenotype reporting). Endorsements from AMP, ASCPT, ASHP, CAP, and ClinGen lend institutional legitimacy, and CPIC® is a registered service mark of the U.S. Department of Health & Human Services.

CPIC does not earn commercial revenue. All guidelines and data are released under Creative Commons (CC0 for guidelines, CC BY-SA for data) at no cost to users worldwide. Operating funding flows from NIH grants, supplemented by an international consortium membership program that requires a signed MOU. End users include healthcare providers, clinical laboratories, researchers, EHR vendors, and indirectly patients receiving PGx-guided therapy; documented clinical outcomes include a reported 30% reduction in adverse drug reactions in pretherapeutic PGx panel testing studies.

Clinical Pharmacogenetics Implementation Consortium (CPIC) firmographics

Firmographics
Name
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Legal name
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Website
https://cpicpgx.org
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
CPIC is a nonprofit international consortium that develops and freely distributes peer-reviewed, evidence-based pharmacogenetic clinical practice guidelines and a structured gene-drug database, serving clinicians, clinical laboratories, researchers, and EHR vendors worldwide under NIH funding.
Ownership category
akta.pro rank

Clinical Pharmacogenetics Implementation Consortium (CPIC) industry classification

Industry
Product category
Clinical Pharmacogenomics Guidelines
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • Pharmacogenomics guidelines
  • Clinical decision support
  • Gene-drug pair annotations
  • EHR integration
  • Pharmacogenetic testing

Where Clinical Pharmacogenetics Implementation Consortium (CPIC) is headquartered

Location

Headquarters

HQ city
Memphis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Clinical Pharmacogenetics Implementation Consortium (CPIC) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

  1. NIH Funding: CPIC is managed at Stanford University and St. Jude Children's Research Hospital under NIH grants (U24HG013077). As a non-profit research consortium, CPIC operations are funded through NIH/NHGRI/NICHD/NIDA/NCI grants rather than commercial revenue generation.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree access to all CPIC resources

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Clinical Pharmacogenetics Implementation Consortium (CPIC) product offering

Product offering

Core offering

CPIC is an international consortium that creates, curates, and posts freely available, peer-reviewed, evidence-based gene/drug clinical practice guidelines that translate pharmacogenetic test results into actionable prescribing decisions. Core offerings include the CPIC Guidelines, a structured CPIC Database with a public REST API (api.clinpgx.org), gene reference tables, allele function/diplotype-phenotype resources, and informatics tools for Electronic Health Records and Clinical Decision Support integration.

Product overview

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international consortium that develops and freely distributes peer-reviewed, evidence-based clinical practice guidelines for pharmacogenetics. CPIC's core offering is its guidelines (covering gene-drug pairs), accessible via a public API and database. The ecosystem includes PharmGKB (knowledge base), CPIC (guidelines), and PharmCAT (variant identification tool). CPIC guidelines translate genetic laboratory results into actionable prescribing decisions and are indexed in PubMed. The consortium provides supplementary resources including gene tables, allele downloads, SOPs for allele curation, implementation guides for EHR integration, and educational materials. All CPIC resources are freely available under Creative Commons (CC0 for guidelines, CC BY-SA for data).

Differentiator

Problem solved

Functional benefit

Products and services

  • CPIC Guidelines Peer-reviewed, evidence-based, updatable clinical practice guidelines that translate pharmacogenetic test results into actionable prescribing decisions for specific gene-drug pairs. Guidelines follow standardized formats with systematic grading of evidence and clinical recommendations, published in partnership with Clinical Pharmacology and Therapeutics and indexed in PubMed.
  • CPIC Database and API Structured access to CPIC guideline data including gene-drug pair information, allele function assignments, diplotype-to-phenotype translations, and clinical recommendations. Available via REST API and database downloads with versioned releases on GitHub.
  • Gene Tables Reference tables providing curated PGx evidence for genes, including allele function and diplotype-phenotype relationships for pharmacogenes used by clinicians and laboratories.
  • CPIC Publications Repository of 56+ peer-reviewed scientific articles written or contributed to by the ClinPGx team, covering implementation guidelines, literature annotations, and supporting research, available as downloadable TSV.
  • CPIC Informatics Working Group Resources Technical resources supporting EHR integration, including comprehensive genotype-to-phenotype translation tables, clinical decision support recommendations, and formal knowledge representations for electronic health records.
  • PharmCAT A companion tool for identifying pharmacogenetic variants from genomic data and generating phenotype reports, developed as part of the ClinPGx ecosystem alongside PharmGKB and CPIC. Managed at Stanford University and University of Pennsylvania.

Quantifiable outcome

  • PGx-guided therapy can reduce adverse drug reactions and healthcare costs
  • +1 more outcomes

Companies that use Clinical Pharmacogenetics Implementation Consortium (CPIC)

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Clinical Pharmacogenetics Implementation Consortium (CPIC) technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Clinical Pharmacogenetics Implementation Consortium (CPIC) partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and major.

  • PharmGKB (Pharmacogenomics Knowledge Base)coreStrategic or Co-development Partner · 1 January 2009PharmGKB and CPIC have a foundational partnership. CPIC started as a shared project between PharmGKB and the Pharmacogenomics Research Network (PGRN) in 2009. PharmGKB provides the infrastructure for ClinPGx, which comprises PharmGKB, CPIC, and PharmCAT. CPIC guidelines are hosted on the ClinPGx platform.
  • Pharmacogenomics Research Network (PGRN)coreStrategic or Co-development PartnerCPIC started as a shared project between PharmGKB and PGRN in 2009. PGRN is a research network focused on pharmacogenomics research that collaborated with PharmGKB to launch CPIC.
  • Association for Molecular Pathology (AMP)majorStrategic or Co-development PartnerAMP has endorsed CPIC's Term Standardization for Clinical Pharmacogenetics Test Results Project. This endorsement supports the standardization of pharmacogenetic test result terminology across clinical laboratories.
  • American Society for Clinical Pharmacology and Therapeutics (ASCPT)majorStrategic or Co-development PartnerASCPT Board of Directors has endorsed CPIC guidelines. CPIC guidelines are published in partnership with ASCPT's journal Clinical Pharmacology and Therapeutics.
  • American Society of Health-System Pharmacists (ASHP)majorStrategic or Co-development PartnerASHP has endorsed multiple CPIC guidelines, indicating support for the use of pharmacogenetic guidelines in health-system pharmacy practice.
  • College of American Pathologists (CAP)majorStrategic or Co-development PartnerCAP has stated that it 'applauds and supports the objectives, processes and work completed' by CPIC, recognizing efforts to help clinicians, laboratories, healthcare providers, and vendors implement pharmacogenetics.
  • ClinGen (Clinical Genome Resource)coreStrategic or Co-development PartnerClinGen references CPIC guidelines. ClinPGx is an affiliate grant of ClinGen and works with ClinGen and ClinVar to improve integration of pharmacogenomics within broader genomic medicine. CPIC's Steering Committee is referred to as CPIC's External Expert Panel.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Clinical Pharmacogenetics Implementation Consortium (CPIC) competitors and assessment

Company assessment

Direct peers

  • PharmCAT: Companion tool in the ClinPGx ecosystem that calls PGx variants from genomic data and produces phenotype reports that feed directly into CPIC guidelines for clinical interpretation.
  • PharmGKB (Pharmacogenomics Knowledge Base): Foundational partner and sister organization in the ClinPGx ecosystem; together with CPIC provides annotation, evidence, and implementation assets for pharmacogenomics, and shares NIH funding and Stanford stewardship.
  • Clinical Genome Resource (ClinGen): NIH-funded consortium that defines clinical relevance of genes and variants; CPIC is an affiliate grant of ClinGen, and ClinGen references CPIC guidelines to integrate PGx into broader genomic medicine.
  • National Comprehensive Cancer Network (NCCN): Produces widely adopted, evidence-based clinical practice guidelines (for oncology); analogous operating model to CPIC in authoring and disseminating consensus-driven, peer-reviewed clinical guidance.
  • American College of Medical Genetics and Genomics (ACMG): Professional society that issues evidence-based clinical genomics guidelines and standards overlapping CPIC's domain; relevant comparator for clinical genomics guideline development and dissemination.
  • Association for Molecular Pathology (AMP): Endorser of CPIC's Term Standardization project and a peer organization producing molecular pathology practice guidelines; comparable in producing clinical and laboratory standards for genomic testing.
  • Pharmacogenomics Research Network (PGRN): Co-founding organization of CPIC in 2009; NIH-funded research network advancing pharmacogenomics research with overlapping scientific leadership and mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Clinical Pharmacogenetics Implementation Consortium (CPIC) social profiles

Digital presence

Clinical Pharmacogenetics Implementation Consortium (CPIC) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinical Pharmacogenetics Implementation Consortium (CPIC) leadership team

Management profile

Number of profiles

Profiles3 records

Clinical Pharmacogenetics Implementation Consortium (CPIC) funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinical Pharmacogenetics Implementation Consortium (CPIC) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Pharmacogenetics Implementation Consortium (CPIC)

What does Clinical Pharmacogenetics Implementation Consortium (CPIC) do?

CPIC is an international consortium that creates, curates, and posts freely available, peer-reviewed, evidence-based gene/drug clinical practice guidelines that translate pharmacogenetic test results into actionable prescribing decisions. Core offerings include the CPIC Guidelines, a structured CPIC Database with a public REST API (api.clinpgx.org), gene reference tables, allele function/diplotype-phenotype resources, and informatics tools for Electronic Health Records and Clinical Decision Support integration.

Is Clinical Pharmacogenetics Implementation Consortium (CPIC) a public or private company?

Clinical Pharmacogenetics Implementation Consortium (CPIC) is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Clinical Pharmacogenetics Implementation Consortium (CPIC) founded?

Clinical Pharmacogenetics Implementation Consortium (CPIC) was founded in 2009. It employs 1 to 10 people.

Where is Clinical Pharmacogenetics Implementation Consortium (CPIC) based?

Clinical Pharmacogenetics Implementation Consortium (CPIC) is headquartered in Memphis, United States, in the North America region.

How does Clinical Pharmacogenetics Implementation Consortium (CPIC) make money?

One revenue line is on record: NIH Funding.

Who are Clinical Pharmacogenetics Implementation Consortium (CPIC)'s main competitors?

Direct peers on record are PharmCAT, PharmGKB (Pharmacogenomics Knowledge Base), Clinical Genome Resource (ClinGen), National Comprehensive Cancer Network (NCCN), American College of Medical Genetics and Genomics (ACMG), Association for Molecular Pathology (AMP) and Pharmacogenomics Research Network (PGRN).

Does Clinical Pharmacogenetics Implementation Consortium (CPIC) have an API?

Yes. CPIC data (from CPIC guideline publications and supporting materials) are available in structured formats via the CPIC database (DB) and API. The API provides access to guideline data for gene-drug pairs, allele information, and clinical recommendations. Documentation and data releases are available via GitHub. Users can submit DB/API bugs or issues via GitHub or email. Developer documentation is at github.com/cpicpgx/cpic-data/wiki.

What industry is Clinical Pharmacogenetics Implementation Consortium (CPIC) in?

Clinical Pharmacogenetics Implementation Consortium (CPIC)'s product category is Clinical Pharmacogenomics Guidelines. Its primary akta.pro industry code is HLAIAKAC, Value Dossier & Evidence Generation (AMCP/Global Value Dossier). Its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales